eFFECTOR Therapeutics Inc. (NASDAQ: EFTR)
$0.19
+0.1090 ( +135.40% ) 1.6M
eFFECTOR Therapeutics Inc is a clinical-stage biopharmaceutical company focused on pioneering the development of a new class of oncology drugs referred to as selective translation regulator inhibitors (STRIs).
Market Data
Open
$0.19
Previous close
$0.08
Volume
1.6M
Market cap
$0.61M
Day range
$0.13 - $0.26
52 week range
$0.03 - $20.61
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
pre | Proxies and info statements | 13 | Apr 16, 2024 |
8-k | 8K-related | 14 | Apr 04, 2024 |
10-k | Annual reports | 107 | Mar 26, 2024 |
8-k | 8K-related | 16 | Mar 25, 2024 |
4 | Insider transactions | 1 | Feb 21, 2024 |
4 | Insider transactions | 1 | Feb 21, 2024 |
4 | Insider transactions | 1 | Feb 21, 2024 |
4 | Insider transactions | 1 | Feb 21, 2024 |
4 | Insider transactions | 1 | Feb 21, 2024 |
4 | Insider transactions | 1 | Feb 21, 2024 |